US Stock Insider Trading | Medline disclosed 15 insider transactions on March 12

robot
Abstract generation in progress

On March 12, 2026, Medline (MDLN) disclosed 15 insider trading transactions. Shareholder Carlyle Group Inc., holding more than 10% of shares, sold 26.1058 million shares on March 10, 2026.

【Recent Insider Transactions】

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
March 12, 2026 Shareholder with over 10% BCP 8 Holdings Mozart Manager L.L.C., BX Mozart ML-2 Holdco L.P., Hellman & Friedman Capital Partners X (Parallel), L.P. March 10, 2026 Sell 81.8372 million 40.51 3.32B
March 12, 2026 Shareholder with over 10% Carlyle Group Inc., CP Circle ML Holdco GP, LLC, TC Group Cayman Investment Holdings, L.P. March 10, 2026 Sell 78.3175 million 41.00 3.21B
December 22, 2025 Shareholder with over 10% Mozart Aggregator II LP December 18, 2025 Sell 13.4626 million 28.37 382 million
December 22, 2025 Shareholder with over 10% Carlyle Group Inc., TC Group VII S1, L.L.C. December 18, 2025 Sell 38.2727 million 29.00 1.11 billion
December 22, 2025 Director Mills Andrew J., Mills Charles N. December 18, 2025 Buy 5.1655 million 29.00 150 million

【Company Profile】

Medline Inc. was incorporated in Delaware on November 6, 2024. The company is the largest supplier of medical surgical products and supply chain solutions, serving all care points based on total net sales of healthcare products. The company provides essential products used daily across various care settings, from hospitals and surgical centers to physicians’ offices and emergency post-acute facilities. Through its Medline brand and supply chain solutions divisions, the company offers medical surgical products, including surgical and procedure kits, gloves and protective apparel, urology and incontinence care, wound care, and consumables for laboratories and diagnostics.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin